All ICD10 Codes
Chapter 21

Z00–Z99: Factors Influencing Health Status and Contact with Health Services

Factors Influencing Health Status and Contact with Health Services diagnostic classification updated for 2026.

All CodesBillable Only
Internal Codes
PrevNext
  • Z13.84—

    Encounter for screening for dental disorders

  • Z13.850—

    Encounter for screening for traumatic brain injury

  • Z13.858—

    Encounter for screening for other nervous system disorders

  • Z13.88—

    Encounter for screening for disorder due to exposure to contaminants

  • Z13.89—

    Encounter for screening for other disorder

  • Z13.9—

    Encounter for screening, unspecified

  • Z14.01—

    Asymptomatic hemophilia A carrier

  • Z14.02—

    Symptomatic hemophilia A carrier

  • Z14.1—

    Cystic fibrosis carrier

  • Z14.8—

    Genetic carrier of other disease

  • Z15.01—

    Genetic susceptibility to malignant neoplasm of breast

  • Z15.02—

    Genetic susceptibility to malignant neoplasm of ovary

  • Z15.03—

    Genetic susceptibility to malignant neoplasm of prostate

  • Z15.04—

    Genetic susceptibility to malignant neoplasm of endometrium

  • Z15.05—

    Genetic susceptibility to malignant neoplasm of fallopian tube(s)

  • Z15.060—

    Genetic susceptibility to colorectal cancer

  • Z15.068—

    Genetic susceptibility to other malignant neoplasm of digestive system

  • Z15.07—

    Genetic susceptibility to malignant neoplasm of urinary tract

  • Z15.09—

    Genetic susceptibility to other malignant neoplasm

  • Z15.1—

    Genetic susceptibility to epilepsy and neurodevelopmental disorders

  • Z15.2—

    Genetic susceptibility to obesity

  • Z15.3—

    Genetic susceptibility to kidney disease

  • Z15.81—

    Genetic susceptibility to multiple endocrine neoplasia [MEN]

  • Z15.89—

    Genetic susceptibility to other disease

  • Z16.10—

    Resistance to unspecified beta lactam antibiotics

  • Z16.11—

    Resistance to penicillins

  • Z16.12—

    Extended spectrum beta lactamase (ESBL) resistance

  • Z16.13—

    Resistance to carbapenem

  • Z16.19—

    Resistance to other specified beta lactam antibiotics

  • Z16.20—

    Resistance to unspecified antibiotic

  • Z16.21—

    Resistance to vancomycin

  • Z16.22—

    Resistance to vancomycin related antibiotics

  • Z16.23—

    Resistance to quinolones and fluoroquinolones

  • Z16.24—

    Resistance to multiple antibiotics

  • Z16.29—

    Resistance to other single specified antibiotic

  • Z16.30—

    Resistance to unspecified antimicrobial drugs

  • Z16.31—

    Resistance to antiparasitic drug(s)

  • Z16.32—

    Resistance to antifungal drug(s)

  • Z16.33—

    Resistance to antiviral drug(s)

  • Z16.341—

    Resistance to single antimycobacterial drug

  • Z16.342—

    Resistance to multiple antimycobacterial drugs

  • Z16.35—

    Resistance to multiple antimicrobial drugs

  • Z16.39—

    Resistance to other specified antimicrobial drug

  • Z17.0—

    Estrogen receptor positive status [ER+]

  • Z17.1—

    Estrogen receptor negative status [ER-]

  • Z17.21—

    Progesterone receptor positive status

  • Z17.22—

    Progesterone receptor negative status

  • Z17.31—

    Human epidermal growth factor receptor 2 positive status

  • Z17.32—

    Human epidermal growth factor receptor 2 negative status

  • Z17.410—

    Hormone receptor positive with human epidermal growth factor receptor 2 positive status

PreviousPage 4 of 29Next